2023
DOI: 10.1088/1748-605x/ad0fa1
|View full text |Cite
|
Sign up to set email alerts
|

Decellularized extracellular matrix scaffold seeded with adipose-derived stem cells promotes neurorestoration and functional recovery after spinal cord injury through Wnt/β-catenin signaling pathway regulation

Xiaochen Su,
Menghao Teng,
Yingang Zhang
et al.

Abstract: Spinal cord injury (SCI) causes tissue destruction and neuronal apoptosis, which impede neural function recovery. Therefore, promoting neuronal regeneration and neural pathway reconstruction is crucial. In this study, a novel and facile decellularized extracellular matrix (dECM) scaffold seeded with adipose-derived stem cells (ADSCs) (dECM scaffolds/ADSCs) was reported. The dECM scaffold maintained the original three-dimensional network structure of spinal cord tissue and contained various small pores. In vitr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 42 publications
0
2
0
Order By: Relevance
“…ESCs [222], iPSCs [43,223], NSCs/NPCs [224,225], MSCs [180,181], OPCs [226], DPSCs [216] and ADSCs [227] Olfactory ensheathing cells [228] and Schwann cells [229] Microglia [230] Directly reprogrammed NPCs (drNPCs) [231][232][233] Gene therapies Nucleic acid-based therapies Delivery methods Other siRNA to AQP-4 [234], nNOS [235], iNOS [236], IL-6 [237], claudin-5 [238], RhoA [239,240], PLK-4 [241], PTEN [242,243], Sema3A [244], CTGF [245], combinatorial [246] and in combination with MSCs [242] Nanoparticle-coated siRNA [247][248][249], polymer nanocarriers [239], exosome delivery [243,245] extracellular vesicles [250], intrathecal delivery [240], photomechanical wave [251] and intranasal delivery [242] Chemogenetic stimulation [252]…”
Section: Neural Cells Immune Cells Advanced Cell Therapiesmentioning
confidence: 99%
See 1 more Smart Citation
“…ESCs [222], iPSCs [43,223], NSCs/NPCs [224,225], MSCs [180,181], OPCs [226], DPSCs [216] and ADSCs [227] Olfactory ensheathing cells [228] and Schwann cells [229] Microglia [230] Directly reprogrammed NPCs (drNPCs) [231][232][233] Gene therapies Nucleic acid-based therapies Delivery methods Other siRNA to AQP-4 [234], nNOS [235], iNOS [236], IL-6 [237], claudin-5 [238], RhoA [239,240], PLK-4 [241], PTEN [242,243], Sema3A [244], CTGF [245], combinatorial [246] and in combination with MSCs [242] Nanoparticle-coated siRNA [247][248][249], polymer nanocarriers [239], exosome delivery [243,245] extracellular vesicles [250], intrathecal delivery [240], photomechanical wave [251] and intranasal delivery [242] Chemogenetic stimulation [252]…”
Section: Neural Cells Immune Cells Advanced Cell Therapiesmentioning
confidence: 99%
“…Other Hydrogels [180,181,253,254], PLGA [255] and PLA [256] Collagen [181,257], CS [258], silk [259,260], decellularised ECM [227], modified gelatine [261] R-GSIK [262], electrospun nanofiber nets [263] and gene scaffolds [264] Gold nanoparticle nerve guidance conduits [265] and collagen conduits [266] Graphene oxide [267], IGF-1 delivery via nanofibrous dural substitutes [197] and ROS scavenger materials [170,171] Table 2. Cont.…”
Section: Nerve Guidancementioning
confidence: 99%